Pharmacists To Get New Substitution Powers To Tackle Brexit Shortage Risk
Executive Summary
In an effort to address possible serious drug shortages in the event of a no-deal Brexit, the UK government has formally proposed giving pharmacists wide powers to dispense alternative medicines such as different forms, generics, biosimilars, or “therapeutically equivalent” drugs.You may also be interested in...
‘No-Deal Brexit’ Pharmacy Substitution Rules Take Effect In UK
UK pharmacists can now dispense a different medicine from the one prescribed, even if it contains a different active ingredient, under new laws on “serious shortage protocols” that came into force on 1 July as part of the government’s “no-deal Brexit” preparations.
How The UK Regulatory System Would Work In A No-Deal Brexit – Part 1
Regulations that would allow the UK MHRA to work as a standalone regulator in the event of a no-deal Brexit have been laid before parliament. They cover a host of areas including new drug approval procedures, conversion of existing EU marketing authorizations into UK ones, pediatric and orphan exclusivities, imported medicines, and regulatory fees.
UK Committee Urges Clarity On No-Deal Brexit Medicine Supplies
A parliamentary committee has called on the health department to provide more clarity as to how it plans to ensure continuity of medicine supplies in the event of a no-deal Brexit. At the same time, the government has produced a set of draft regulations allowing the UK MHRA to take over drug regulatory functions currently performed at EU level.
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports
New to Pink Sheet?
Start a free trial today!
Register for our free email digests:
Register for our free email digests:
